Abbott Laboratories news

   Watch this stock
Showing stories 1 - 10 of about 127   

Articles published

ABT 42.55
price chart
Abbott Labs Approves $3 Billion in Buybacks
The buyback authorization is in addition to the $511 million remaining under Abbott's previous $3 billion share repurchase program, which was approved in June 2013.
Abbott Labs (ABT) to Repurchase Shares for $3B  Zacks.com
Abbott plans $3 billion share buyback  Chicago Tribune
Related articles »  
Johnson & Johnson vs. Abbott Laboratories in the Battle for Emerging Market Turf
Based on my 8 rules of dividend investing (more on that below), Abbott Laboratories has the advantage, but Johnson & Johnson is a fantastic company as well.
Related articles »  
Abbott Labs' Weakness in Devices Hurts Long-Term Growth Potential
NEW YORK (TheStreet) -- By conventional valuation methods, shares of Abbott Laboratories (ABT) aren't expensive. In fact, it's easy to argue that Abbott is one of the best bargains in medical technology.
Related articles »  
Abbott Labs' 'Sugar High' is Just What the Doctor Ordered
Abbott Laboratories (ABT) - This medical device maker announced Wednesday that it received CE Mark for its FreeStyle Libre Flash Glucose Monitoring System.
Stock Update: Abbott Laboratories (NYSE:ABT) � Abbott Receives CE Mark for ...  Jutia Group
Abbott Gets EU Approval For Glucose Monitoring System  Bidness ETC
Related articles »  
Abbott Laboratories: An Emerging Markets Growth Play With Increasing Dividends
Abbott Laboratories (NYSE:ABT) is a diversified healthcare products company that is now focused on nutritional products, diagnostics, generic drugs, and medical devices.
Related articles »  
Paul Ryan's take on why Abbott Labs hasn't built a Wisconsin plant
In his new book, Paul Ryan adds another chapter to the politicization of Abbott Laboratories' flirtation with opening a new plant in the Kenosha area.
Market Update: Abbott Laboratories (NYSE:ABT) � Abbott Commences Tender ...
25, 2014 /PRNewswire/ - Abbott (ABT) today announced that its wholly-owned subsidiary, Abbott Laboratories (Chile) Holdco (Dos) SpA, a Chilean corporation (�ALH�), has commenced a tender offer (the �U.
Abnormal Volume Gains- Abbott Laboratories (NYSE:ABT), T-Mobile (NYSE ...  eMarketsDaily
Stock Buzz-Abbott Laboratories (NYSE:ABT) , Wyndham Worldwide Corporation ...  Techsonian (press release)
Related articles »  
Abbott Labs Begins Tender Offer For CFR Pharma - Quick Facts
Diversified healthcare company Abbott Laboratories (ABT: Quote) said Monday that its wholly-owned subsidiary, Abbott Laboratories (Chile) Holdco (Dos) SpA, a Chilean corporation or "ALH, has commenced a tender offer or the "U.S. Offer", in which it is ...
Abbott Commences Tender Offer for All Outstanding Ordinary Shares and ...  CNNMoney
Related articles »  
Abbott Is Getting Expensive On A Fundamental Basis (ABT)
The last time I analyzed Abbott Laboratories (NYSE:ABT) on July 5, 2014, I stated, "Like I said, I will only be buying a small batch this time around, only for the dividend.
Stock Update: Abbott Laboratories (NYSE:ABT) � New Abbott Technology May ...
Abbott Laboratories (NYSE:ABT) [PR Newswire] - WASHINGTON, Sept. 8, 2014 /PRNewswire/ - A new study suggests a pioneering testing technology could reduce hospital stays by up to eight days and lower annual health care costs for people with ...
Related articles »